SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001133416-24-000056
Filing Date
2024-10-16
Accepted
2024-10-16 16:12:20
Documents
1
Period of Report
2024-10-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5254
  Complete submission text file 0001133416-24-000056.txt   6783
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 712 LAKEWAY DRIVE KELLER TX 76248
Business Address
FREEMAN KEVIN D (Reporting) CIK: 0001522478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 241374728